UK Markets close in 3 hrs 10 mins

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
27.64-1.20 (-4.16%)
At close: 04:00PM EST
27.53 -0.11 (-0.40%)
After hours: 04:18PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts6266
Avg. Estimate-0.42-0.41-1.64-1.75
Low estimate-0.47-0.43-1.69-2.01
High estimate-0.38-0.4-1.6-1.61
Year ago EPS-0.36-0.55-2.02-1.64
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts5255
Avg. Estimate1.04M650k5.34M2.2M
Low estimateN/AN/A4.3MN/A
High estimate3.48M1.3M7.8M5M
Year ago sales3.79M685k7.42M5.34M
Sales growth (year/est)-72.50%-5.10%-28.00%-58.80%
Earnings history29/09/202030/12/202029/06/202129/09/2021
Est. EPS-0.36-0.37-0.4-0.36
Actual EPS-0.36-0.55-0.34-0.45
Difference0-0.180.06-0.09
Surprise %0.00%-48.60%15.00%-25.00%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.42-0.41-1.64-1.75
7 days ago-0.42-0.41-1.64-1.75
30 days ago-0.42-0.41-1.64-1.75
60 days ago-0.38-0.41-1.5-1.73
90 days ago-0.38-0.41-1.5-1.73
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCLDXIndustrySector(s)S&P 500
Current qtr.-16.70%N/AN/AN/A
Next qtr.25.50%N/AN/AN/A
Current year18.80%N/AN/AN/A
Next year-6.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A